[EN] HIGHLY SELECTIVE AKR1C3 INHIBITORS AND METHODS OF USE THEREOF<br/>[FR] INHIBITEURS D'AKR1C3 HAUTEMENT SÉLECTIFS ET LEURS PROCÉDÉS D'UTILISATION
申请人:UNIV TEXAS TECH SYSTEM
公开号:WO2018148721A1
公开(公告)日:2018-08-16
The present invention includes methods and compositions that inhibit AKR1C3 enzymatic activity and consequently reduces androgen receptor (AR) transactivation, AR and prostate specific antigen (PSA) expression levels in, for example, prostate cancer, castration-resistant prostate cancer, breast cancer, acute myeloid leukemia (AML), T-cell acute lymphoblastic leukemia (T-ALL), or a leukemia.
本发明涵盖了抑制AKR1C3酶活性的方法和组合物,从而降低雄激素受体(AR)的转录活性,AR和前列腺特异性抗原(PSA)在例如前列腺癌、去势抵抗性前列腺癌、乳腺癌、急性髓性白血病(AML)、T细胞急性淋巴细胞白血病(T-ALL)或白血病中的表达水平。